Headquarters
Israel

MeMed Diagnostics

MeMed’s mission is to transform infectious disease healthcare by translating the complex signals of the immune system into simple diagnostics, ensuring the right treatment at the right place and the right time. MeMed has developed and validated MeMed BV™, an immune-based protein signature to distinguish accurately between bacterial and viral infections, an indispensable tool in the fight against antibiotic overuse and antimicrobial resistance, one of the biggest healthcare challenges today. MeMed is also developing MeMed Key™, a platform to measure multiple proteins and signatures, conventional and innovative, with central lab precision at the point of care.

MeMed Diagnostics のウェブサイトを見る

MeMed Diagnostics からの寄稿者

メルマガの登録

グローバル・アジェンダのウィークリー・アップデート

© 2022 World Economic Forum

プライバシーポリシーと利用規約